A strong performance at home saw South African hospital group Mediclinic's revenue grow 8% in the financial year ending March 31, 2022 and its EBITDA margin move up two percentage points to 16%.
The next round of the French election is just two weeks off, and unexpectedly the race between Marine Le Pen and incumbent Emmanuel Macron is closer than many predicted. HBI asks, what would a Le Pen government mean for for-profit healthcare?
The number of ransomware attacks targeting the healthcare sector is increasing exponentially. Multiple recent surveys have found that it is now one of the most targeted sectors of the economy, with as many as one in three of the world’s healthcare organisations being targeted in 2020. This poses a major threat not just to healthcare organisations' finances but also lives. We speak to two cybersecurity experts to find out what healthcare operators can do to protect themselves and their patients.
Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.
The Turkish Lira has been consistently depreciating, losing three-quarters of its US dollar value in the last five years. HBI speaks with an operator source, as well as consultants and operators from Turkey, to find out their strategy to hedge against a worsening exchange rate.
Swiss investment group Aevis Victoria achieved strong financial results in 2021, thanks in large part to sales of stakes in hospital group Swiss Medical Network and ambulance group Swiss Ambulance Rescue Genève and a return to normality seen in both the healthcare and hospitality sectors.
Asia's largest for-profit healthcare group IHH Healthcare has made a buyout offer to Malaysian-based hospital group Ramsay Sime Darby Health Care (RSDHD) of US$1.35bn.
As China's biggest city Shanghai faces a staggered Covid lockdown, HBI catches up with a Chinese healthcare expert who tells us that premium international operators could be significantly hit.
Europe, with its often rigorous divides between research institutes and university hospitals, has fallen a long way behind power houses such as MIT/Harvard/Mass General in the generation of applied medical science. So how do you build a successful healthcare science cluster in Europe?
As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
